The goal of the IMMUNOLOGY AND PATHOLOGY CORE is to provide a centralized facility for performing a range of assays and services that facilitate the functional and anatomical analysis of cells and tissues by CFAR investigators. This facility provides the biosafety containment that is necessary for these analyses. Services provided by this core include RNA and protein analyses for cytokines, chemokines and growth factors, as well as tissue fixation, slide preparation and histopathology using microscopic examination, immunohistochemical and in situ hybridization techniques. We will soon offer additional cutting edge technology by providing use of an inverted fluorescence microscope to analyze HIV infected living cells and unfixed tissues. This core provides a key service, as an understanding of the mechanisms that mediate HIV and opportunistic infection and tissue responses requires an analysis of the factors being elaborated by and the phenotypes of infected cells as well as the response to infection by uninfected resident cells. Therefore, access to these services greatly supports the diverse research efforts of investigators at Einstein and Montefiore aimed at understanding the pathogenesis of infection with HIV-1 and AIDS-associated pathogens.
Aim 1. To provide investigators with the research infrastructure that is necessary to analyze the immune responses stimulated by HIV and AIDS-associated pathogens by measuring cytokine, chemokine and other soluble mediator, RNA, and protein levels in the appropriate biosafety containment.
Aim 2. To provide investigators with a facility using appropriate biohazard containment that is capable of examining the effects of infection with HIV and AIDS-associated pathogens on tissues by characterizing morphological, molecular and phenotypical changes using histological, immunohistochemical, in situ hybridization analyses and live cell imaging.
Aim 3. To train CFAR investigators in the performance of techniques that are extant in the Core and to assist investigators in the development of new immunological assays and pathological techniques that are required for the accomplishment of their research projects.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-EC-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine
United States
Zip Code
Rao, Vasudev R; Neogi, Ujjwal; Eugenin, Eliseo et al. (2014) The gp120 protein is a second determinant of decreased neurovirulence of Indian HIV-1C isolates compared to southern African HIV-1C isolates. PLoS One 9:e107074
Singh, M; Quispe-Tintaya, W; Chandra, D et al. (2014) Direct incorporation of the NKT-cell activator ?-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy. Br J Cancer 111:1945-54
Jelen, Mateja M; Chen, Zigui; Kocjan, Boštjan J et al. (2014) Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences. J Virol 88:7307-16
Tarassishin, Leonid; Suh, Hyeon-Sook; Lee, Sunhee C (2014) LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14. Glia 62:999-1013
Strickler, Howard D; Martinson, Jeffrey; Desai, Seema et al. (2014) The relation of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV-uninfected women. Viral Immunol 27:20-5
Tarassishin, Leonid; Casper, Diana; Lee, Sunhee C (2014) Aberrant expression of interleukin-1? and inflammasome activation in human malignant gliomas. PLoS One 9:e103432
Prados-Rosales, Rafael; Carreño, Leandro J; Batista-Gonzalez, Ana et al. (2014) Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis. MBio 5:e01921-14
Stec, Jozef; Vilchèze, Catherine; Lun, Shichun et al. (2014) Biological evaluation of potent triclosan-derived inhibitors of the enoyl-acyl carrier protein reductase InhA in drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis. ChemMedChem 9:2528-37
Benning, Lorie; Golub, Elizabeth T; Anastos, Kathryn et al. (2014) Comparison of lower genital tract microbiota in HIV-infected and uninfected women from Rwanda and the US. PLoS One 9:e96844
Shuter, Jonathan; Moadel, Alyson B; Kim, Ryung S et al. (2014) Self-efficacy to quit in HIV-infected smokers. Nicotine Tob Res 16:1527-31

Showing the most recent 10 out of 381 publications